Case Study on Moderna Published by Harvard Business School:
— Brook Jackson 💜 (@IamBrookJackson) January 22, 2023
"The level of reckless disregard for product safety, rational drug design, rigorous testing and quality control in biologics manufacturing is astounding." – Sasha Latypova https://t.co/No4l9lwTyt
The “BANZAI” digital break or the 21st Century definition of FAT CAT
https://twitter.com/MarioNawfal/status/2049159706514493541

